BioLife Solutions, Inc. Forecast, price target & analysts
BioLife Solutions, Inc. Target price 2025 - Analyst rating & recommendation
BioLife Solutions, Inc. Classifications & Recommendation:
BioLife Solutions, Inc. Price Target
| Target Price | $31.62 |
| Price | $25.93 |
| Potential |
21.94%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target BioLife Solutions, Inc. 2026 .
The average BioLife Solutions, Inc. target price is $31.62.
This is
21.94%
register free of charge
$35.70
37.68%
register free of charge
$30.30
16.85%
register free of charge
|
|
| A rating was issued by 16 analysts: 15 Analysts recommend BioLife Solutions, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioLife Solutions, Inc. stock has an average upside potential 2026 of
21.94%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 82.25 | 103.35 |
| 8.42% | 25.65% | |
| EBITDA Margin | -5.34% | 23.52% |
| 79.67% | 540.67% | |
| Net Margin | -24.53% | -17.00% |
| 72.63% | 30.71% |
12 Analysts have issued a sales forecast BioLife Solutions, Inc. 2025 . The average BioLife Solutions, Inc. sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an BioLife Solutions, Inc. EBITDA forecast 2025. The average BioLife Solutions, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 BioLife Solutions, Inc. Analysts have issued a net profit forecast 2025. The average BioLife Solutions, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.43 | -0.37 |
| 72.26% | 13.95% | |
| P/E | negative | |
| EV/Sales | 11.33 |
12 Analysts have issued a BioLife Solutions, Inc. forecast for earnings per share. The average BioLife Solutions, Inc. EPS is
This results in the following potential growth metrics and future valuations:
BioLife Solutions, Inc....
Current BioLife Solutions, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 13 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 06 2025 |
| Northland Capital Markets |
Locked
➜
Locked
|
Locked | Jan 08 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | Dec 19 2024 |
| Keybanc |
Locked
➜
Locked
|
Locked | Dec 13 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 06 2025 |
|
Locked
Northland Capital Markets:
Locked
➜
Locked
|
Jan 08 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Dec 19 2024 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Dec 13 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 18 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
